Episodic Migraine Definition

fewer than 15 headache days per month . Unlike chronic migraine , which involves 15 or more days of headache per month, episodic migraine is characterized by distinct attacks with symptom-free intervals in between. Miles For Migraine +3 Review of Episodic Migraine 1. Classification and Frequency Medical professionals further categorize episodic migraine based on the monthly frequency of attacks to determine the best management strategy : Low-Frequency Episodic Migraine (LFEM): Fewer than 10 migraine days per month. High-Frequency Episodic Migraine (HFEM): 10 to 14 migraine days per month. This group often experiences a disability level similar to chronic migraine . 2. Clinical Features and Phases An episodic migraine attack is a complex sensory process typically consisting of four overlapping phases: 10 sites Comprehensive Guide to Managing Episodic Migraine Mar 27, 2024 —

Episodic Migraine is a distinct clinical entity defined by recurrent headache attacks lasting 4 to 72 hours, featuring specific pain characteristics and associated symptoms of nausea or sensory sensitivity. It is primarily differentiated from Chronic Migraine by a frequency of fewer than 15 headache days per month. Accurate definition and sub-classification (with or without aura) are essential for selecting appropriate acute and preventive therapies and for preventing the transformation of episodic attacks into chronic conditions. episodic migraine definition

While defined by the "less than 15 days" threshold, the severity of Episodic Migraine varies significantly among patients. It is often stratified clinically to determine treatment intensity: fewer than 15 headache days per month

To be classified as migraine (either with or without aura), a patient must have experienced at least five attacks fulfilling the following criteria: episodic migraine definition

The headache attack lasts 4 to 72 hours if untreated or unsuccessfully treated.

| Feature | Episodic Migraine | Chronic Migraine | | :--- | :--- | :--- | | | < 15 days | ≥ 15 days (for >3 months) | | Prevalence | ~90-95% of people with migraine | ~5-10% of people with migraine | | Disability | Lower (typically interictal normal function) | Higher (often daily impairment) | | Treatment approach | Acute (abortive) + prevention if needed | Preventive treatment essential; limit acute meds | | Risk of progression | Lower (but modifiable risk factors exist) | Higher (can reverse to EM with treatment) |